olympia glp 1 GLP-1 Agonists for Weight Loss Medical Weight Loss with GLP-1
Description
The primary outcome was change in HbA1c from randomisation to the end of treatment, secondary outcomes included body weight change
The FDA has approved three GLP-1 receptor agonist drugs for weight loss
Propensity score fine stratification weighted Cox proportional hazards models were fitted to estimate hazard ratios and 95% confidence intervals (CIs) to estimate the average treatment effect among the treated patients
Not for individuals under 18. Consult a healthcare professional if pregnant, breastfeeding, or on medication
Sharing my personal journey with GLP-1 and what this 'face transformation' truly felt like
